Literature DB >> 12099754

Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.

Alan J Hunter1, Richard E Bryant.   

Abstract

The routine management of cutaneous mucormycosis consists of combined surgical and medical therapy. We present a case of successful medical therapy with sequential liposomal amphotericin B and itraconazole for a peri-ostomal cutaneous Rhizopus infection in a 59-year-old woman following treatment for pyoderma gangrenosum in the setting of inflammatory bowel disease. Copyright 2002 The British Infection Society.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12099754     DOI： 10.1053/jinf.2002.0972

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  5 in total

1.  Mucormycosis of the intestine: a rare complication in Crohn's disease.

Authors:  Jordan Morton; Vincent Nguyen; Tauseef Ali
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

2.  In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Teresa Peláez; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

3.  Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy.

Authors:  Shane M Devlin; Bing Hu; Andrew Ippoliti
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

4.  Posaconazole as salvage therapy for zygomycosis.

Authors:  R N Greenberg; K Mullane; J-A H van Burik; I Raad; M J Abzug; G Anstead; R Herbrecht; A Langston; K A Marr; G Schiller; M Schuster; J R Wingard; C E Gonzalez; S G Revankar; G Corcoran; R J Kryscio; R Hare
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature.

Authors:  Maheen Z Abidi; Nayantara Coelho-Prabhu; James Hargreaves; Tim Weiland; Irminne Van Dyken; Aaron Tande; Pritish K Tosh; Randall C Walker; Nathan W Cummins
Journal:  Case Rep Med       Date:  2014-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.